P/E at 60.03 vs Industry's 66.62: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

At a P/E of 60.03, Apollo Hospitals Enterprise Ltd. trades at approximately a 9.8% discount to its hospital industry peers, whose average P/E stands at 66.62. This valuation gap is significant given the company’s stature as a large-cap leader with a market capitalisation of ₹1,25,211.99 crores. The discount suggests that investors may be pricing in either a moderation in growth expectations or a cautious stance on near-term earnings momentum. However, the premium valuation of the sector overall reflects robust demand and growth prospects in healthcare services, making the stock’s relative valuation an intriguing point of analysis — previously rated Strong Buy, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Momentum Divergence

The stock’s performance over the past year has been resilient, delivering a 10.21% gain while the Sensex declined by 5.03%. This outperformance extends over longer horizons as well, with three-year returns of 80.56% and five-year returns of 73.74%, both substantially ahead of the Sensex’s 16.81% and 31.88% respectively. The ten-year return is particularly striking at 534.21%, underscoring the company’s sustained growth trajectory over the past decade.

Yet, the shorter-term momentum tells a different story. Over the past month, the stock has declined by 2.39%, slightly underperforming the Sensex’s 2.26% fall. The one-week and one-day performances also show underperformance, with losses of 1.55% and 0.86% respectively, compared to the Sensex’s smaller declines or gains. Interestingly, the three-month return remains positive at 5.56%, outpacing the Sensex’s 3.09% gain. This pattern suggests a recent softening in momentum after a period of steady gains — is this a temporary pause or a sign of deeper weakness?

Moving Average Configuration: Mixed Technical Signals

The technical setup of Apollo Hospitals Enterprise Ltd. reveals a nuanced picture. The stock currently trades above its 100-day and 200-day moving averages, indicating a longer-term bullish trend. However, it remains below the 5-day, 20-day, and 50-day moving averages, signalling short-term pressure and a possible consolidation phase. This configuration often reflects a stock in a recovery phase within a broader uptrend, where recent selling has tempered momentum but the underlying trend remains intact. The 5-day and 20-day averages acting as resistance levels could be key hurdles for the stock to regain upward momentum — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Performance Context: Hospital Industry Trends

The hospital sector has demonstrated robust performance over the past year, buoyed by increasing healthcare demand and expanding service offerings. While specific sector-wide performance data is not detailed here, the industry’s elevated average P/E of 66.62 reflects investor confidence in sustained earnings growth. Within this context, Apollo Hospitals Enterprise Ltd. stands out for its large-cap status and consistent outperformance over multiple timeframes. The sector’s positive momentum contrasts with the stock’s recent short-term softness, highlighting the importance of monitoring both company-specific and sector-wide developments — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Reassessment: Previously Strong Buy

On 1 September 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Strong Buy. The current Mojo Score stands at 77.0, reflecting a solid overall assessment. This rating adjustment comes amid the mixed signals from valuation, performance, and technical indicators. The previous Strong Buy rating was supported by the company’s dominant market position and growth prospects, but the reassessment suggests a more cautious stance given recent momentum shifts and valuation considerations — what is the current rating?

Conclusion: A Complex Data Narrative

The data on Apollo Hospitals Enterprise Ltd. paints a multifaceted picture. The stock’s valuation discount relative to its sector peers contrasts with its strong long-term performance and large-cap stature. However, recent short-term underperformance and a mixed moving average configuration suggest caution. The rating update from Strong Buy to a more measured assessment reflects these complexities. Investors analysing this stock must weigh the premium valuation environment of the hospital sector against the nuanced signals from momentum and technical indicators — should investors in Apollo Hospitals hold, buy more, or reconsider?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today